IBDEI0JN ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9127,1,4,0)
 ;;=4^H59.41
 ;;^UTILITY(U,$J,358.3,9127,2)
 ;;=^5006426
 ;;^UTILITY(U,$J,358.3,9128,0)
 ;;=H59.42^^41^474^45
 ;;^UTILITY(U,$J,358.3,9128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9128,1,3,0)
 ;;=3^Inflammation of Postprocedural Bleb,Stage 2
 ;;^UTILITY(U,$J,358.3,9128,1,4,0)
 ;;=4^H59.42
 ;;^UTILITY(U,$J,358.3,9128,2)
 ;;=^5006427
 ;;^UTILITY(U,$J,358.3,9129,0)
 ;;=H59.43^^41^474^46
 ;;^UTILITY(U,$J,358.3,9129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9129,1,3,0)
 ;;=3^Inflammation of Postprocedural Bleb,Stage 3
 ;;^UTILITY(U,$J,358.3,9129,1,4,0)
 ;;=4^H59.43
 ;;^UTILITY(U,$J,358.3,9129,2)
 ;;=^5006428
 ;;^UTILITY(U,$J,358.3,9130,0)
 ;;=H59.40^^41^474^47
 ;;^UTILITY(U,$J,358.3,9130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9130,1,3,0)
 ;;=3^Inflammation of Postprocedural Bleb,Unspec
 ;;^UTILITY(U,$J,358.3,9130,1,4,0)
 ;;=4^H59.40
 ;;^UTILITY(U,$J,358.3,9130,2)
 ;;=^5006425
 ;;^UTILITY(U,$J,358.3,9131,0)
 ;;=H54.8^^41^474^48
 ;;^UTILITY(U,$J,358.3,9131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9131,1,3,0)
 ;;=3^Legal Blindness,as Defined in USA
 ;;^UTILITY(U,$J,358.3,9131,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,9131,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,9132,0)
 ;;=H40.1231^^41^474^35
 ;;^UTILITY(U,$J,358.3,9132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9132,1,3,0)
 ;;=3^Glaucoma,Low-Tension,Mild Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,9132,1,4,0)
 ;;=4^H40.1231
 ;;^UTILITY(U,$J,358.3,9132,2)
 ;;=^5005768
 ;;^UTILITY(U,$J,358.3,9133,0)
 ;;=H40.1232^^41^474^36
 ;;^UTILITY(U,$J,358.3,9133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9133,1,3,0)
 ;;=3^Glaucoma,Low-Tension,Moderate Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,9133,1,4,0)
 ;;=4^H40.1232
 ;;^UTILITY(U,$J,358.3,9133,2)
 ;;=^5005769
 ;;^UTILITY(U,$J,358.3,9134,0)
 ;;=H40.1233^^41^474^37
 ;;^UTILITY(U,$J,358.3,9134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9134,1,3,0)
 ;;=3^Glaucoma,Low-Tension,Severe Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,9134,1,4,0)
 ;;=4^H40.1233
 ;;^UTILITY(U,$J,358.3,9134,2)
 ;;=^5005770
 ;;^UTILITY(U,$J,358.3,9135,0)
 ;;=H52.13^^41^474^49
 ;;^UTILITY(U,$J,358.3,9135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9135,1,3,0)
 ;;=3^Myopia,Bilateral
 ;;^UTILITY(U,$J,358.3,9135,1,4,0)
 ;;=4^H52.13
 ;;^UTILITY(U,$J,358.3,9135,2)
 ;;=^5006266
 ;;^UTILITY(U,$J,358.3,9136,0)
 ;;=H52.12^^41^474^50
 ;;^UTILITY(U,$J,358.3,9136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9136,1,3,0)
 ;;=3^Myopia,Left Eye
 ;;^UTILITY(U,$J,358.3,9136,1,4,0)
 ;;=4^H52.12
 ;;^UTILITY(U,$J,358.3,9136,2)
 ;;=^5006265
 ;;^UTILITY(U,$J,358.3,9137,0)
 ;;=H52.11^^41^474^51
 ;;^UTILITY(U,$J,358.3,9137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9137,1,3,0)
 ;;=3^Myopia,Right Eye
 ;;^UTILITY(U,$J,358.3,9137,1,4,0)
 ;;=4^H52.11
 ;;^UTILITY(U,$J,358.3,9137,2)
 ;;=^5006264
 ;;^UTILITY(U,$J,358.3,9138,0)
 ;;=H40.053^^41^474^52
 ;;^UTILITY(U,$J,358.3,9138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9138,1,3,0)
 ;;=3^Ocular HTN,Bilateral
 ;;^UTILITY(U,$J,358.3,9138,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,9138,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,9139,0)
 ;;=H40.052^^41^474^53
 ;;^UTILITY(U,$J,358.3,9139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9139,1,3,0)
 ;;=3^Ocular HTN,Left Eye
 ;;^UTILITY(U,$J,358.3,9139,1,4,0)
 ;;=4^H40.052
 ;;^UTILITY(U,$J,358.3,9139,2)
 ;;=^5005741
 ;;^UTILITY(U,$J,358.3,9140,0)
 ;;=H40.051^^41^474^54
 ;;^UTILITY(U,$J,358.3,9140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9140,1,3,0)
 ;;=3^Ocular HTN,Right Eye
 ;;^UTILITY(U,$J,358.3,9140,1,4,0)
 ;;=4^H40.051
 ;;^UTILITY(U,$J,358.3,9140,2)
 ;;=^5005740
